149 related articles for article (PubMed ID: 23877521)
1. Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Jul; 39(7):650-2. PubMed ID: 23877521
[TBL] [Abstract][Full Text] [Related]
2. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
[TBL] [Abstract][Full Text] [Related]
3. MRI and FDG PET/CT findings of malignant fibrous histiocytoma of the prostate.
Dong A; Gong J; Wang Y; Zuo C
Clin Nucl Med; 2014 Oct; 39(10):889-91. PubMed ID: 24217548
[TBL] [Abstract][Full Text] [Related]
4. Prognostic utility of squamous cell carcinoma antigen in carcinoma of the cervix: association with pre- and posttreatment FDG-PET.
Olsen JR; Dehdashti F; Siegel BA; Zighelboim I; Grigsby PW; Schwarz JK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):772-7. PubMed ID: 20888130
[TBL] [Abstract][Full Text] [Related]
5. Parotid gland metastasis from squamous cell carcinoma of esophagus detected by FDG PET/CT.
Hsieh TC; Wu YC; Sun SS; Yang CF; Kao CH
Clin Nucl Med; 2012 Oct; 37(10):1001-2. PubMed ID: 22955076
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.
Shiiba M; Ishihara K; Kimura G; Kuwako T; Yoshihara H; Sato H; Kondo Y; Tsuchiya S; Kumita S
Ann Nucl Med; 2012 Feb; 26(2):138-45. PubMed ID: 22069194
[TBL] [Abstract][Full Text] [Related]
7. Is further evaluation needed for incidental focal uptake in the prostate in 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography images?
Hwang I; Chong A; Jung SI; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K; Ryu SB
Ann Nucl Med; 2013 Feb; 27(2):140-5. PubMed ID: 23076866
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
9. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG-PET/CT predicts survival in hypopharyngeal squamous cell carcinoma.
Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Maruo T; Naganawa S; Hasegawa Y; Nakashima T
Ann Nucl Med; 2013 Apr; 27(3):297-302. PubMed ID: 23337965
[TBL] [Abstract][Full Text] [Related]
11. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
Yilmaz M; Celen Z; Sevinc A; Karakok M
Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
[TBL] [Abstract][Full Text] [Related]
12. Positron-emission tomography pitfalls related to oral prosthesis.
More Y; Dusing R; Counts S; Bond J; Tsue T; Girod D
Laryngoscope; 2013 Feb; 123(2):404-6. PubMed ID: 22778055
[TBL] [Abstract][Full Text] [Related]
13. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
14. Definitive chemo-radiotherapy for squamous cell carcinoma of the pharynx: impact of baseline low hemoglobin level (<12 g/dL) and post-radiation therapy F-18 FDG-PET/CT.
Katahira-Suzuki R; Hata M; Tateishi U; Taguchi T; Takano S; Omura-Minamisawa M; Inoue T
Ann Nucl Med; 2015 Jan; 29(1):37-45. PubMed ID: 25228378
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
[TBL] [Abstract][Full Text] [Related]
17. Primary squamous cell carcinoma of the thyroid on FDG PET/CT.
Cai L; Chen Y; Huang Z; Wu J
Clin Nucl Med; 2014 Nov; 39(11):1014-6. PubMed ID: 24999700
[TBL] [Abstract][Full Text] [Related]
18. FDG PET imaging in a patient with primary seminoma of the prostate.
Hayasaka K; Koyama M; Fukui I
Clin Nucl Med; 2011 Jul; 36(7):593-4. PubMed ID: 21637070
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma.
Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K
AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716
[TBL] [Abstract][Full Text] [Related]
20. The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.
Nakamura K; Okumura Y; Kodama J; Hongo A; Kanazawa S; Hiramatsu Y
Gynecol Oncol; 2010 Oct; 119(1):81-6. PubMed ID: 20580064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
